Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

This study has been terminated.
(Other new drugs)
Sponsor:
Information provided by (Responsible Party):
French Innovative Leukemia Organisation
ClinicalTrials.gov Identifier:
NCT00920153
First received: June 12, 2009
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)